Flora Growth CORP

ZeroStack Corp. has finalized a private cryptocurrency financing, acquiring 142,232,948 Zero Gravity (0G) blockchain tokens.

ZeroStack Corp. shareholders approved amendments to the 2022 Incentive Compensation Plan, increasing share availability and updating company name references.

ZeroStack Corp. announced the grant of stock options to its CEO, CFO, and Executive Chairman, with vesting tied to specific stock price performance milestones.

ZeroStack Corp. announced a series of strategic transactions including the acquisition of Texas Blocker Corp. via a share exchange and the settlement of a convertible note, aiming for U.S. domestic tax classification.

Flora Growth Corp. officially changed its corporate name to ZeroStack Corp. and its Nasdaq ticker symbol to ZSTK, effective January 29, 2026.

Flora Growth Corp. announced the appointment of Larry Zeifman as a new independent director and Audit Committee Chair, filling a previous vacancy, and Manfred Leventhal as Nominating Committee Chair.

ZeroStack Corp. reports increased revenue driven by digital asset staking, but a significant net loss due to digital asset value depreciation and operational costs.

Flora Growth Corp. is rebranding as ZeroStack, pivoting to a decentralized AI treasury strategy with significant 0G Token investments while divesting its legacy hemp and cannabis operations.

Flora Growth Corp. reported a decrease in revenue and gross profit for the six months ended June 30, 2025, while reducing its net loss, as it navigates strategic acquisitions, subsidiary insolvencies, and a pending reverse stock split to address Nasdaq's minimum bid price requirement.

Flora Growth Corp. reports a decrease in revenue for Q1 2025 compared to Q1 2024, driven by lower sales in key segments and strategic decisions to streamline operations.

Flora Growth Corp. reported a decrease in revenue for the third quarter of 2024, alongside a net loss, as the company navigates strategic changes and market challenges.

Flora Growth Corp. reports a decrease in revenue for the second quarter of 2024, alongside strategic cost-cutting measures and acquisitions.

ZeroStack Corp. transitioned to a decentralized AI treasury and asset management strategy in 2025, reporting a significant net loss of $119.7 million primarily due to digital asset fair value changes, while divesting its legacy cannabis business.

Flora Growth Corp. files its annual report, detailing its financial results for the year ended December 31, 2024, and outlining its business strategy and key developments.

Flora Growth Corp.'s 10-K filing reveals a year of strategic changes, including divestments and acquisitions, alongside financial results reflecting both growth and challenges.

Michael Heinrich, Executive Chairman and a Director of Flora Growth Corp., purchased 4,608,575 shares of common stock on July 20, 2026 for $0.75 per share.

Daniel Reis-Faria, CEO and a Director of Flora Growth Corp., reported multiple transactions in common stock on July 20, 2026.

Dany Vaiman, CFO of Flora Growth Corp., received 250,000 shares of common stock on July 20, 2026.

Laurence Zeifman, a Director at ZeroStack Corp., has acquired 28,000 stock options with an exercise price of $5.10, vesting over time.

Edward Woo, a Director at ZeroStack Corp., has acquired 35,000 stock options with an exercise price of $5.10, vesting over time.

Manfred Leventhal, a Director at ZeroStack Corp., acquired 35,000 stock options with an exercise price of $5.10, vesting over time.

Flora Growth Corp. calls a Special Meeting to approve a name change to ZeroStack Corp., new preferred shares, expanded equity compensation, and share issuances for digital asset strategy.

Flora Growth Corp. is set to hold its 2025 Annual and Special Meeting of Shareholders on June 30, 2025, seeking approval for several key proposals including director elections, auditor re-appointment, an amendment to the incentive compensation plan, stock appreciation rights grants, a share consolidation, and repricing of outstanding SARs.

Flora Growth Corp. has filed a definitive proxy statement regarding its 2024 Annual and Special Meeting of Shareholders, detailing proposals including director elections, auditor re-appointment, an incentive plan amendment, stock appreciation rights, and a share issuance for acquiring TruHC Pharma GmbH.

Flora Growth Corp., soon to be ZeroStack, is undergoing a major strategic shift towards AI infrastructure and digital assets, backed by significant private placements and a new $50 million equity line of credit.

Daniel Reis-Faria, CEO of ZeroStack Corp., has increased his beneficial ownership to 37.5% through the exercise of pre-funded warrants and a significant stock option grant.

Dany Vaiman, CFO of ZeroStack Corp., reports beneficial ownership of 513,249 shares (2.9%) and details a shareholder-approved stock option grant tied to VWAP performance.

Michael Heinrich and Zero Gravity Labs Inc. report beneficial ownership of 30.2% and 26.4% of ZeroStack Corp. common shares respectively, totaling over 56% combined.

Michael Heinrich and Zero Gravity Labs Inc. have filed an amendment to their Schedule 13D concerning ZeroStack Corp., detailing a note settlement agreement and beneficial ownership.

Flora Growth Corp. granted its Chairman and CEO, Michael Heinrich, 471,208 stock options with an exercise price of $7.31 per share, vesting upon specific volume weighted average price thresholds.

Flora Growth Corp.'s CFO, Dany Vaiman, increased his beneficial ownership to 23.8% through a grant of 235,604 stock options with performance-based vesting.

Highbridge Capital Management, LLC has reported a 4.4% beneficial ownership stake in Flora Growth Corp., primarily through warrants.

Highbridge Capital Management, LLC has disclosed a 5.1% beneficial ownership stake in Flora Growth Corp., primarily through warrants, as detailed in a recent Schedule 13G filing with the SEC.

Empery Asset Management, LP, along with its managing members Ryan M. Lane and Martin D. Hoe, has filed an amended Schedule 13G disclosing a 1.92% beneficial ownership stake in Flora Growth Corp.

Empery Asset Management, LP, along with its managing members Ryan M. Lane and Martin D. Hoe, has disclosed a passive beneficial ownership of 5.36% in Flora Growth Corp.'s common shares.